A Phase 3 Biomarker Validation of GALAD for the Detection of Hepatocellular Carcinoma in Cirrhosis

CheckMate 9DW Trial: Nivolumab + Ipilimumab for Unresectable HCC

August 17, 2026

Linerixibat for Cholestatic Pruritus in PBC: Phase 3 Results from the GLISTEN Trial

July 13, 2026

Can a shorter acetylcysteine regimen be used for paracetamol overdose? The SARPO Trial

June 3, 2026